PB8-15228-66421 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-17
Registered in v-safe
2020-12-18
Dose 1 — Pfizer-BioNTech
2021-01-06
Dose 2 — Pfizer-BioNTech
2021-01-10
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-10
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-12
Survey response — days 1–6 daily, dose 2
MedDRA: Pruritus — Feeling: Fair · Fever · Headache, Fatigue or tiredness, Nausea, Diarrhea

Free text: Total body itchiness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-09-01
Dose 3 — Pfizer-BioNTech
2021-09-28
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-03-04
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-18	Pfizer-BioNTech
2	2021-01-06	Pfizer-BioNTech
3	2021-09-01	Pfizer-BioNTech	No

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-12

Systemic reaction (other): Total body itchiness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Pruritus	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release